HER2-Positive Breast Cancer Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
HER2-Positive Breast Cancer Market is segmented By Treatment Type (Chemotherapy, Immunotherapy), By Route of Administration (Oral, Parenteral, Others), By End-user (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned.
Competitive overview of HER2-Positive Breast Cancer Market
The major players operating in the HER2-Positive Breast Cancer Market include Jiangsu HengRui Medicine Co., Ltd., Shanghai Henlius Biotech, Merus N.V., GeneQuantum, Roche/Genentech, Amgen, AstraZeneca, Boehringer Ingelheim, Genetech, Johnson & Johnson, Cipla, Abbvie and Merck.
HER2-Positive Breast Cancer Market Leaders
- Jiangsu HengRui Medicine Co., Ltd.
- Shanghai Henlius Biotech
- Merus N.V.
- GeneQuantum
- Roche
*Disclaimer: Major players are listed in no particular order.
HER2-Positive Breast Cancer Market - Competitive Rivalry, undefined
HER2-Positive Breast Cancer Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights